BlackRock, Inc. - 30 Jun 2025 SCHEDULE 13G/A Report for SPYRE THERAPEUTICS INC Common Stock (SYRE)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: SPYRE THERAPEUTICS INC Common Stock
Symbol: SYRE
Shares outstanding: 60M shares
Disclosed Ownership: 3.96M shares
Ownership: 6.6%
Form type: SCHEDULE 13G/A
Filing time: 16 Jul 2025, 19:02:16 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	6.6%	3.96M	3.87M	0	Spencer Fleming	Managing Director